Biocon has reported results for first quarter ended June 30, 2023 (Q1FY24).
The company has reported over 3- fold jump in its net profit at Rs 46.60 crore for the quarter under review as compared to Rs 14.90 crore for the same quarter in the previous year. Total income of the company increased by 12.01% at Rs 549.20 crore for Q1FY24 as compared Rs 490.30 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 11.05% fall in its net profit at Rs 148.90 crore for the first quarter ended June 30, 2023 as compared to Rs 167.40 crore for the same quarter in the previous year. However, total income of the company increased by 58.57% at Rs 3516.10 crore for Q1FY24 as compared Rs 2217.40 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |